Minor
Nivolumab and Lenalidomide · Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Trial completed
Also in this update: Study completion date changed from estimate of Dec 31, 2026 to Aug 28, 2026
David Bond, MDPhase 1/2 NCT03015896 Registry history of NCT03015896 on ClinicalTrials.gov (opens the registry)